The Australian Health Practitioner Regulation Agency (Ahpra) and the National Boards recognise that registered health practitioners have led the remarkable public health response to the COVID-19 pandemic in Australia and commend them for their sustained efforts.
The Australian Technical Advisory Group on Immunisation (ATAGI) recently recommended that the interval at which people become eligible for a booster be reduced to five months, and that Moderna can be used as a booster.
Practices can claim the Medicare Benefits Schedule (MBS) COVID-19 vaccine suitability assessment items for children aged 5 to 11 years, as they have done with other cohorts.
New MBS remote supervision items will be introduced on 1 January 2022 to improve access to vaccines and booster shots for those unable to attend a vaccination site.
The Australian Society for Psychological Medicine (ASPM) is launching three Focused Psychological Strategies Skill Training ‘Level 2’ series in 2022 delivered online by GP’s for GP’s.
The College has been advised that the Pharmaceutical Benefits Advisory Committee (PBAC) has not recommended making amendments to the existing Pharmaceutical Benefits Scheme (PBS) listings of antipsychotic medications.
Lynn Saul, who has held a range of management positions in our education services area, finishes with the College this month. The College would like to celebrate Lynn’s huge contribution to the body of work underpinning the ACRRM Fellowship program.
As you may be aware, the Government has announced that from 1 January 2022 the Rural Bulk Billing Incentive under the Medicare Benefits Schedule (MBS) will increase for doctors working in remote areas and rural towns based on the Modified Monash Model (MMM). This change will also apply to the Veterans’ Access Payments (VAP) for services provided to DVA clients.
Recent changes to the Medicare Telehealth Item numbers are significant for rural patients as they are likely to directly impact affordable care and immediately reduce regional, rural and remote service delivery.
The Australian Government has updated the criteria for access to PPE for general practices supporting COVID-positive patients. In addition to the current arrangements, eligibility for PPE bundles has been expanded to additional settings.
ACRRM is seeking to fill one of the two representative positions for the College on the Conjoint Committee for Pre-Hospital and Retrieval Medicine (CCPHRM), the group responsible for broader governance of the Diploma of Pre-hospital and Retrieval Medicine (DipPHRM).
A booster dose is now available to anyone in Australia aged 18 years and over who has completed their primary course of vaccination at least six-months ago. ATAGI has advised that in special circumstances, the six-month interval may be shortened to five months when needed for logistical reasons.
The Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer vaccine as safe and effective for use for 5 to 11-year-old children in Australia.
Asthma Australia has invited the College to participate as a project ambassador to develop national research priorities for asthma as determined by people with lived experience, their carers, treating health professionals and policy makers.
A few words from Dermatologist Dr Jim Muir on the benefits of the Tele-Derm service, free for ACRRM members, and non-members who are doctors working in rural and remote locations.
The Commonwealth Department of Health is reminding prescribers and dispensers of the approaching end date for the final extension of the image-based prescribing arrangements on 31 December 2021.